FDA approves a new type 2 diabetes drug that works in combination with Metformin

On January 20th, the FDA announced approval of a new sodium-glucose cotransporter 2 (SGLT2) inhibitor for treatment of type 2 diabetes in adults. The new drug is produced by Theracos, a privately held pharmaceutical research and development company located in Marlborough, Massachusetts. The drug will be marketed under the name Brenzavvy (generic name: bexagliflozin). The […]

Introducing the new once-a-day pill for Type 2 diabetes that replaces weekly injections

In 2017, a new drug came onto the market that radically improved therapy for adult sufferers of Type 2 diabetes. That new treatment is a once-a-week self-injectable dose of Ozempic, and it contains a newly developed drug called semaglutide. Now, the drug company Novartis that developed Ozempic has released a pill-form of semaglutide that can […]

November is National Diabetes Month

November is National Diabetes Month. In 2022, the theme is sharing ways you can work with health care professionals to build a team to help you manage your diabetes. The Center for Disease Control and Prevention lists some of the most common dangers that come with diabetes as: Heart disease and stroke. People with diabetes […]